Pharmaceuticals · Market research

Lung Cancer Therapeutics reports

Coverage across 33 countries and regions. Researched figures and forecasts come with the full report.

Get the full Lung Cancer Therapeutics market evidence

The purchased report supplies researched market size, forecast, growth, segments, competition and sources.

Buy the full report Request free sample
Lung Cancer Therapeutics reports by place
PlaceCurrent sizeForecastGrowthActive trialsReport
WorldIn full reportIn full reportIn full report4,180View report
AfricaIn full reportIn full reportIn full report37View report
APACIn full reportIn full reportIn full report1,734View report
AustraliaIn full reportIn full reportIn full report292View report
BrazilIn full reportIn full reportIn full report158View report
CanadaIn full reportIn full reportIn full report328View report
ChinaIn full reportIn full reportIn full report1,447View report
EcuadorIn full reportIn full reportIn full report0View report
EgyptIn full reportIn full reportIn full report10View report
EuropeIn full reportIn full reportIn full report876View report
FranceIn full reportIn full reportIn full report481View report
GermanyIn full reportIn full reportIn full report297View report
Hong KongIn full reportIn full reportIn full report105View report
IndiaIn full reportIn full reportIn full report69View report
ItalyIn full reportIn full reportIn full report394View report
JapanIn full reportIn full reportIn full report283View report
KenyaIn full reportIn full reportIn full report1View report
Latin AmericaIn full reportIn full reportIn full report190View report
MalaysiaIn full reportIn full reportIn full report66View report
MexicoIn full reportIn full reportIn full report100View report
Middle EastIn full reportIn full reportIn full report16View report
New ZealandIn full reportIn full reportIn full report18View report
North AmericaIn full reportIn full reportIn full report1,648View report
PhilippinesIn full reportIn full reportIn full report22View report
RussiaIn full reportIn full reportIn full report62View report
Saudi ArabiaIn full reportIn full reportIn full report9View report
SingaporeIn full reportIn full reportIn full report84View report
South AfricaIn full reportIn full reportIn full report24View report
SpainIn full reportIn full reportIn full report445View report
ThailandIn full reportIn full reportIn full report91View report
UAEIn full reportIn full reportIn full report3View report
UKIn full reportIn full reportIn full report290View report
USIn full reportIn full reportIn full report1,568View report

Public clinical research

4,180 active trials found worldwide on ClinicalTrials.gov.

See the public search

Latest public research

  1. Heart-lung-on-a-chip featuring dynamic flow-resistance capture for drug-associated cardiac dysfunction assessment under tumor-immune-conditioned drug exposure.Lab on a chip, 2026
  2. Phenylalanine- and tryptophan-based hydrazone hybrids targeting the VEGF axis and caspase-mediated apoptosis: Design, synthesis, and biological evaluation.Bioorganic chemistry, 2026
  3. Surfaceome Reprogramming of Stemsomes Promotes Lung Cancer Targeting via Potentiated Receptor-Ligand Interactions.Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026
  4. Aromatic amino acid based Schiff base copper(II) complexes as potential lung cancer therapeutics: Biological and antioxidant activity, DNA/BSA interaction, mesogenic properties, molecular docking and DFT study.Journal of inorganic biochemistry, 2025
  5. Multicolor SERS-encoded immuno-cocktail for longitudinal precise tracking of CTCs phenotypes in lung cancer therapeutics.Biosensors & bioelectronics, 2025

Public trial and paper counts come from ClinicalTrials.gov and PubMed. Acuitas market figures are not published on this page.